Investor Relations

Press Releases

All Releases
View Summary OPKO Licensee TESARO Receives FDA Approval for VARUBI™ (rolapitant)
Sep 2, 2015
PDF 65.7 KB
View Summary OPKO Letter to Shareholders
Aug 26, 2015
PDF 31.6 KB
View Summary OPKO Health to Be Present at the Barrington Research Fall Investment Conference
Aug 25, 2015
PDF 8.4 KB
View Summary OPKO Completes Acquisition of Bio-Reference Laboratories
Aug 20, 2015
PDF 13.9 KB
View Summary OPKO Lab Signs Contracts with Leading Preferred Provider Networks for Laboratory Testing Services Including the 4Kscore® Test
Aug 19, 2015
PDF 19.8 KB
View Summary OPKO Announces Second Quarter Operating and Financial Results
Aug 5, 2015
PDF 34.1 KB
View Summary Two Reports on hGH-CTP Pediatric Phase 2 Clinical Data Accepted for Oral Presentation at the 54th Annual Meeting of the European Society for Paediatric Endocrinology (ESPE conference)
Aug 5, 2015
PDF 13.2 KB
View Summary OPKO To Announce Second Quarter Operating and Financial Results on August 5, 2015
Jul 30, 2015
PDF 19.5 KB
View Summary FDA Accepts OPKO's New Drug Application for Rayaldee™
Jul 28, 2015
PDF 14.7 KB
View Summary OPKO Announces Completion of Enrollment in Phase 3 Trial of hGH-CTP in Growth Hormone Deficient Adults
Jul 10, 2015
PDF 12.5 KB
View Summary OPKO Investee SciVac Announces the Completion of Transaction with Levon Resources
Jul 10, 2015
PDF 107.2 KB
View Summary OPKO and Bio-Reference Laboratories Announce Early Termination of the Waiting Period for Planned Acquisition
Jul 2, 2015
PDF 18.5 KB
View Summary Conversion Right Extended on OPKO 3.0% Convertible Senior Notes
Jul 1, 2015
PDF 11.0 KB
View Summary OPKO 4Kscore® Recommended in National Comprehensive Cancer Network Guidelines for Prostate Cancer Early Detection
Jun 26, 2015
PDF 12.9 KB
View Summary OPKO to Present New Data at International Society on Thrombosis and Haemostasis (ISTH) 2015 Congress on Its Long-Acting Clotting Factor VIIa
Jun 9, 2015
PDF 14.1 KB
View Summary OPKO and Bio-Reference Laboratories To Hold Joint Conference Call to Discuss Merger
Jun 8, 2015
PDF 21.7 KB
View Summary OPKO Health to Acquire Bio-Reference Laboratories
Jun 4, 2015
PDF 22.4 KB
View Summary OPKO Announces Submission of Rayaldee™ New Drug Application to U.S. Food and Drug Administration
May 29, 2015
PDF 13.6 KB
View Summary OPKO Health to Present at the Jefferies 2015 Healthcare Conference
May 27, 2015
PDF 9.1 KB
View Summary OPKO Announces 4Kscore® Abstracts at the 2015 American Urological Association (AUA) Annual Meeting
May 18, 2015
PDF 13.1 KB
Showing 1-20 of 235 Page: 1 2 3 4 5 ... 12  Next 20